89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 71 filers reported holding 89BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,774,793 | -9.2% | 827,383 | +11.4% | 0.01% | -14.3% |
| Q2 2023 | $14,069,086 | +30.0% | 742,432 | +4.4% | 0.01% | +40.0% |
| Q1 2023 | $10,825,971 | +584.3% | 710,832 | +69.4% | 0.01% | +400.0% |
| Q1 2022 | $1,582,000 | -85.0% | 419,560 | -47.8% | 0.00% | -75.0% |
| Q4 2021 | $10,514,000 | -33.4% | 804,420 | -0.2% | 0.00% | -33.3% |
| Q3 2021 | $15,791,000 | +10.9% | 806,039 | +5.8% | 0.01% | +20.0% |
| Q2 2021 | $14,244,000 | -12.3% | 761,739 | +11.0% | 0.01% | -28.6% |
| Q1 2021 | $16,245,000 | -2.8% | 686,039 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $16,718,000 | -4.8% | 686,039 | +0.2% | 0.01% | -22.2% |
| Q3 2020 | $17,562,000 | +136.8% | 684,400 | +205.8% | 0.01% | +125.0% |
| Q2 2020 | $7,417,000 | +31.3% | 223,800 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,651,000 | -14.0% | 223,800 | -10.5% | 0.00% | +33.3% |
| Q4 2019 | $6,573,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
| Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
| Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
| Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
| Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
| Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
| Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
| Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |